Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease

Bibliographic Details
Main Authors: Naim Shehadeh, Itamar Raz, Afif Nakhleh
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12933-018-0760-6
_version_ 1828483979794186240
author Naim Shehadeh
Itamar Raz
Afif Nakhleh
author_facet Naim Shehadeh
Itamar Raz
Afif Nakhleh
author_sort Naim Shehadeh
collection DOAJ
first_indexed 2024-12-11T08:47:59Z
format Article
id doaj.art-51d631aee65846ddbd8155109e458e6f
institution Directory Open Access Journal
issn 1475-2840
language English
last_indexed 2024-12-11T08:47:59Z
publishDate 2018-08-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj.art-51d631aee65846ddbd8155109e458e6f2022-12-22T01:14:06ZengBMCCardiovascular Diabetology1475-28402018-08-011711310.1186/s12933-018-0760-6Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular diseaseNaim Shehadeh0Itamar Raz1Afif Nakhleh2Institute of Endocrinology, Diabetes and Metabolism, Rambam Health Care CampusDiabetes Unit, Hadassah Hebrew University HospitalInstitute of Endocrinology, Diabetes and Metabolism, Rambam Health Care Campushttp://link.springer.com/article/10.1186/s12933-018-0760-6Diabetes mellitus type 2Mild hyperglycemiaEarly combination therapyCardiovascular diseaseCardiovascular outcomes
spellingShingle Naim Shehadeh
Itamar Raz
Afif Nakhleh
Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
Cardiovascular Diabetology
Diabetes mellitus type 2
Mild hyperglycemia
Early combination therapy
Cardiovascular disease
Cardiovascular outcomes
title Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
title_full Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
title_fullStr Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
title_full_unstemmed Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
title_short Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
title_sort cardiovascular benefit in the limelight shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
topic Diabetes mellitus type 2
Mild hyperglycemia
Early combination therapy
Cardiovascular disease
Cardiovascular outcomes
url http://link.springer.com/article/10.1186/s12933-018-0760-6
work_keys_str_mv AT naimshehadeh cardiovascularbenefitinthelimelightshiftingtype2diabetestreatmentparadigmtowardsearlycombinationtherapyinpatientswithovertcardiovasculardisease
AT itamarraz cardiovascularbenefitinthelimelightshiftingtype2diabetestreatmentparadigmtowardsearlycombinationtherapyinpatientswithovertcardiovasculardisease
AT afifnakhleh cardiovascularbenefitinthelimelightshiftingtype2diabetestreatmentparadigmtowardsearlycombinationtherapyinpatientswithovertcardiovasculardisease